UBS Group’s Guardant Health GH Stock Holding History

UBS Group’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.4M	Hold	9,300	–	–	﹤0.01%	5432
2026 Q1	$859K	Buy	+9,300	New	+$934K	﹤0.01%	5665
2025 Q3	–	Sell	-5,000	Closed	-$260K	–	10527
2025 Q2	$260K	Buy	+5,000	New	+$223K	﹤0.01%	6541
2022 Q4	–	Sell	-40,000	Closed	-$2.15M	–	10863
2022 Q3	$2.15M	Buy	+40,000	New	+$2.05M	﹤0.01%	3096

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

UBS Group's GH Position: Q2 2026 in Review

UBS Group reduced its Guardant Health (GH) stake by 38% in Q2 2026, selling an estimated $58.7M and leaving 866,046 shares worth $130M. The position accounts for 0.02% of the portfolio, ranked #945.

UBS Group first reported a position in GH in Q4 2018 and has held it in 31 quarters since. The position peaked at $175M in Q4 2025. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

UBS Group held 866,046 shares of Guardant Health worth $130M as of Q2 2026.
UBS Group sold 539,791 Guardant Health shares in Q2 2026, an estimated $58.7M.
Guardant Health made up 0.02% of UBS Group's portfolio in Q2 2026, its #945 holding.
UBS Group first reported a position in Guardant Health in Q4 2018 and has held it in 31 quarters since.
UBS Group's Guardant Health position peaked at $175M in Q4 2025.
600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.